Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional study.

ABSTRACT:

Background

Mass drug administration with antibiotics predominantly with azithromycin is one of the four arms of the SAFE strategy. The elimination of ocular chlamydial infection is only achieved as long as the azithromycin mass treatments (AMT) are given frequently enough and at a high enough coverage. This study was conducted to assess the coverage of azithromycin mass treatment and its determinants in Awi Zone, Northwestern Ethiopia.

Methods

House to house survey using a structured questionnaire was done between July 7 to July 25, 2013. Coverage is defined as the proportion of individuals in the eligible population who actually ingested the Azithromycin during the Campaign.

Results

A total of 1267 households were enrolled in the survey in which 5826 eligible members

SUBMITTER: Tilahun Z 

PROVIDER: S-EPMC6091195 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature